NIH – two FOAs on technology R&D for biomedical research

November 7, 2016 by School of Medicine Webmaster

For both of these NIGMS initiatives, standard deadlines apply.

Focused Technology Research and Development (R01) (PAR-17-045)
This initiative will support projects that focus solely on development of technologies with the potential to enable biomedical research. Projects should be justified in terms of potential biomedical impact, but should not include any application to specific biomedical research questions.

Proof of principle for the technology will have already been shown, but there will still be significant fundamental technical challenges. Applications should include preliminary data.

The products of this research will be functioning prototype instruments, methods, synthetic approaches, etc., characterized adequately to be ready for first application to the type of biomedical research questions that provided the rationale for their development.

Exploratory Research for Technology Development (R21) (PAR-17-046)
This initiative will support exploratory research leading to the development of innovative technologies for biomedical research. The program will recognize and reward high risk approaches with potential for significant impact.  Projects will entail a high degree of risk or novelty, which will be offset by a correspondingly high potential impact. However, the possible impact is likely to be far off. Application of the proposed technology to specific biomedical questions is considered beyond the scope of the program, and should not be included. Preliminary data demonstrating feasibility of the proposed approach indicates that the project is beyond the scope of this program and therefore unsuitable for this funding opportunity. 

Filed Under: Funding Opportunities